Home › Companies › BLUEPRINT MEDICINES CORP. › 2023-2024
Compiled from SEC Form N-PX filings and BLUEPRINT MEDICINES CORP.’s Form 8-K, filed June 14, 2024 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 12, 2024: 6 items on BLUEPRINT MEDICINES CORP.’s Form 8-K, filed June 14, 2024: 3 approved · 3 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024 2024-2025
Explore BLUEPRINT MEDICINES CORP. in the interactive database Compare manager voting policies
These tallies are BLUEPRINT MEDICINES CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 14, 2024 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Daniella Beckman | 54,014,668 | -- | -- | 4,259,561 | 2,067,113 | 93% | Not verified | — |
| Elect Director: Habib Dable | 40,783,723 | -- | -- | 17,490,506 | 2,067,113 | 70% | Not verified | — |
| Elect Director: Lynn Seely, M.D. | 42,706,299 | -- | -- | 15,567,930 | 2,067,113 | 73% | Not verified | — |
| 3. The non-binding, advisory vote on the compensation paid to its named executive officers | 56,844,879 | 1,345,313 | 84,037 | -- | 2,067,113 | 98% | Approved | — |
| 4. The Company's stockholders approved the 2024 Plan. | 41,494,784 | 16,766,684 | 12,761 | -- | 2,067,113 | 71% | Approved | — |
| 5. The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting for the fiscal year ending December 31, 2024. | 60,124,981 | 198,317 | 18,044 | -- | -- | 99.6% | Approved | — |
Source: BLUEPRINT MEDICINES CORP., Form 8-K, filed with the SEC on June 14, 2024 — read the filing on EDGAR.
Each item below shows how the 309 asset managers that disclosed a BLUEPRINT MEDICINES CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BLUEPRINT MEDICINES CORP.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Daniella Beckman
BLUEPRINT MEDICINES CORP.’s own tally for this item (“Elect Director: Daniella Beckman”): 54,014,668 for, 4,259,561 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 93% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 99 asset managers below reported 32,353,509 for, 1,642,250 withheld, 415,871 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,825,344 | 0 | 0 | 0 | For |
| Fidelity | 5,991,253 | 0 | 0 | 13,266 | For |
| T. Rowe Price | 5,448,322 | 0 | 0 | 0 | For |
| BlackRock | 3,279,222 | 0 | 0 | 0 | For |
| Lord Abbett | 1,145,420 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 945,166 | 0 | 0 | 0 | For |
| State Street | 821,835 | 0 | 0 | 88 | For |
| JPMorgan | 724,726 | 0 | 0 | 0 | For |
| American Century | 519,467 | 0 | 0 | 0 | For |
| Charles Schwab | 0 | 0 | 0 | 502,210 | Withhold |
| Invesco | 430,463 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 0 | 0 | 428,993 | Withhold |
| WILLIAM BLAIR FUNDS | 350,924 | 0 | 0 | 0 | For |
| Principal | 77,207 | 0 | 0 | 199,517 | Mixed |
| Equitable | 120,284 | 0 | 0 | 141,539 | Mixed |
| TIAA | 261,525 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 231,685 | 0 | 0 | 0 | For |
| Hartford | 222,884 | 0 | 0 | 0 | For |
| Jackson National | 221,771 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 0 | 0 | 212,314 | 0 | Abstain |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 202,784 | Withhold |
| Brown Advisory Funds | 201,802 | 0 | 0 | 0 | For |
| John Hancock | 162,981 | 0 | 31,019 | 0 | Mixed |
| Goldman Sachs | 178,055 | 0 | 0 | 0 | For |
| Brighthouse | 158,646 | 0 | 0 | 17,858 | Mixed |
Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.
Combines 5 wordings of this item as funds reported it.
70% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Habib Dable
BLUEPRINT MEDICINES CORP.’s own tally for this item (“Elect Director: Habib Dable”): 40,783,723 for, 17,490,506 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 70% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 99 asset managers below reported 26,810,163 for, 33 against, 6,760,922 withheld, 840,512 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,825,344 | 0 | 0 | 0 | For |
| Fidelity | 5,991,253 | 0 | 0 | 13,266 | For |
| T. Rowe Price | 5,448,322 | 0 | 0 | 0 | For |
| BlackRock | 3,279,222 | 0 | 0 | 0 | For |
| Lord Abbett | 0 | 0 | 0 | 1,145,420 | Withhold |
| Delaware/Macquarie | 0 | 0 | 0 | 945,166 | Withhold |
| State Street | 870 | 0 | 0 | 821,053 | Withhold |
| JPMorgan | 724,726 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 519,467 | Withhold |
| Charles Schwab | 502,210 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 430,463 | Withhold |
| AllianceBernstein | 0 | 0 | 0 | 428,993 | Withhold |
| WILLIAM BLAIR FUNDS | 0 | 0 | 0 | 350,924 | Withhold |
| Principal | 458 | 0 | 0 | 276,266 | Withhold |
| Equitable | 120,284 | 0 | 0 | 141,539 | Mixed |
| TIAA | 261,525 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 231,685 | 0 | 0 | 0 | For |
| Hartford | 222,884 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 221,771 | 0 | Abstain |
| Manager Directed Portfolios | 212,314 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 202,784 | Withhold |
| Brown Advisory Funds | 0 | 0 | 201,802 | 0 | Abstain |
| John Hancock | 109,582 | 0 | 84,418 | 0 | Mixed |
| Goldman Sachs | 0 | 0 | 0 | 178,055 | Withhold |
| Brighthouse | 37,202 | 0 | 0 | 139,302 | Mixed |
Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.
Combines 5 wordings of this item as funds reported it.
73% Majority: yes · of votes cast
Description as filed by funds: Election of Directors: Lynn Seely
BLUEPRINT MEDICINES CORP.’s own tally for this item (“Elect Director: Lynn Seely, M.D.”): 42,706,299 for, 15,567,930 withheld, per its Form 8-K filed June 14, 2024 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 73% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 99 asset managers below reported 27,682,317 for, 33 against, 5,887,304 withheld, 841,976 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,825,344 | 0 | 0 | 0 | For |
| Fidelity | 5,991,253 | 0 | 0 | 13,266 | For |
| T. Rowe Price | 5,448,322 | 0 | 0 | 0 | For |
| BlackRock | 3,279,222 | 0 | 0 | 0 | For |
| Lord Abbett | 0 | 0 | 0 | 1,145,420 | Withhold |
| Delaware/Macquarie | 0 | 0 | 0 | 945,166 | Withhold |
| State Street | 820,774 | 0 | 0 | 1,149 | For |
| JPMorgan | 724,726 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 519,467 | Withhold |
| Charles Schwab | 502,210 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 430,463 | Withhold |
| AllianceBernstein | 0 | 0 | 0 | 428,993 | Withhold |
| WILLIAM BLAIR FUNDS | 0 | 0 | 0 | 350,924 | Withhold |
| Principal | 458 | 0 | 0 | 276,266 | Withhold |
| Equitable | 120,284 | 0 | 0 | 141,539 | Mixed |
| TIAA | 261,525 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 231,685 | 0 | 0 | 0 | For |
| Hartford | 222,884 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 221,771 | 0 | Abstain |
| Manager Directed Portfolios | 212,314 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 202,784 | Withhold |
| Brown Advisory Funds | 0 | 0 | 201,802 | 0 | Abstain |
| John Hancock | 109,582 | 0 | 84,418 | 0 | Mixed |
| Goldman Sachs | 0 | 0 | 0 | 178,055 | Withhold |
| Brighthouse | 37,202 | 0 | 0 | 139,302 | Mixed |
Showing the 25 largest of 99 asset managers. See all 99 in the interactive database.
Combines 4 wordings of this item as funds reported it.
71% Approved · of votes cast
Description as filed by funds: APPROVAL OF THE BLUEPRINT MEDICINES CORPORATION 2024 STOCK INCENTIVE PLAN.
BLUEPRINT MEDICINES CORP.’s own tally for this item (“4. The Company's stockholders approved the 2024 Plan.”): 41,494,784 for, 16,766,684 against — passed, per its Form 8-K filed June 14, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the 2024 Plan.”
Support: 71% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 101 asset managers below reported 27,872,885 for, 6,540,409 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,825,344 | 0 | 0 | 0 | For |
| Fidelity | 6,004,519 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,448,322 | 0 | 0 | 0 | For |
| BlackRock | 3,279,222 | 0 | 0 | 0 | For |
| Lord Abbett | 0 | 1,145,420 | 0 | 0 | Against |
| Delaware/Macquarie | 0 | 945,166 | 0 | 0 | Against |
| State Street | 870 | 821,053 | 0 | 0 | Against |
| JPMorgan | 724,726 | 0 | 0 | 0 | For |
| American Century | 0 | 519,467 | 0 | 0 | Against |
| Charles Schwab | 502,210 | 0 | 0 | 0 | For |
| Invesco | 0 | 430,463 | 0 | 0 | Against |
| AllianceBernstein | 428,993 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 0 | 350,924 | 0 | 0 | Against |
| Principal | 199,975 | 76,749 | 0 | 0 | Mixed |
| Equitable | 261,823 | 0 | 0 | 0 | For |
| TIAA | 261,525 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 231,685 | 0 | 0 | 0 | For |
| Hartford | 222,884 | 0 | 0 | 0 | For |
| Jackson National | 0 | 221,771 | 0 | 0 | Against |
| Manager Directed Portfolios | 212,314 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 202,784 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 0 | 201,802 | 0 | 0 | Against |
| John Hancock | 109,582 | 84,418 | 0 | 0 | Mixed |
| Goldman Sachs | 0 | 178,055 | 0 | 0 | Against |
| Brighthouse | 37,202 | 139,302 | 0 | 0 | Mixed |
Showing the 25 largest of 101 asset managers. See all 101 in the interactive database.
Combines 11 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: APPROVAL OF A NON-BINDING ADVISORY VOTE ON THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS.
BLUEPRINT MEDICINES CORP.’s own tally for this item (“3. The non-binding, advisory vote on the compensation paid to its named executive officers”): 56,844,879 for, 1,345,313 against — passed, per its Form 8-K filed June 14, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved the non-binding, advisory vote on the compensation paid to its named executive officers.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,825,344 | 0 | 0 | 0 | For |
| Fidelity | 6,004,519 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,448,322 | 0 | 0 | 0 | For |
| BlackRock | 3,279,222 | 0 | 0 | 0 | For |
| Lord Abbett | 1,145,420 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 945,166 | 0 | 0 | 0 | For |
| State Street | 821,923 | 0 | 0 | 0 | For |
| JPMorgan | 724,726 | 0 | 0 | 0 | For |
| American Century | 519,467 | 0 | 0 | 0 | For |
| Charles Schwab | 502,210 | 0 | 0 | 0 | For |
| Invesco | 0 | 430,463 | 0 | 0 | Against |
| AllianceBernstein | 428,993 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 350,924 | 0 | 0 | 0 | For |
| Principal | 276,724 | 0 | 0 | 0 | For |
| Equitable | 261,823 | 0 | 0 | 0 | For |
| TIAA | 261,525 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 231,685 | 0 | 0 | 0 | For |
| Hartford | 222,884 | 0 | 0 | 0 | For |
| Jackson National | 121,855 | 99,916 | 0 | 0 | Mixed |
| Manager Directed Portfolios | 212,314 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 202,784 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 201,802 | 0 | 0 | 0 | For |
| John Hancock | 194,000 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,055 | 0 | 0 | 0 | For |
| Brighthouse | 38,686 | 119,960 | 17,858 | 0 | Mixed |
Fund voting reports, all 100 managers: 33,688,111 for, 709,708 against, 17,858 abstained. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 7,008,524 | 0 | 0 | 0 | For |
| Fidelity | 5,126,016 | 0 | 0 | 0 | For |
| Wellington | 3,861,287 | 0 | 0 | 0 | For |
| Man Group plc | 3,000,550 | 0 | 0 | 0 | For |
| Rock Springs Capital Management LP | 2,498,449 | 0 | 0 | 0 | For |
| BlackRock | 2,115,687 | 0 | 0 | 0 | For |
| New York Life | 2,000,000 | 0 | 0 | 0 | For |
| State Street | 1,984,631 | 0 | 0 | 0 | For |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1,472,544 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 1,351,661 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,316,863 | 0 | 0 | 0 | For |
| LORD, ABBETT & CO. LLC | 1,240,696 | 0 | 0 | 0 | For |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 1,143,760 | 0 | 0 | 0 | For |
| JPMorgan | 1,107,183 | 0 | 0 | 0 | For |
| AllianceBernstein | 1,085,624 | 0 | 0 | 0 | For |
| Woodline Partners LP | 909,910 | 0 | 0 | 0 | For |
| Polar Capital Holdings Plc | 865,000 | 0 | 0 | 0 | For |
| BROWN ADVISORY INC | 566,454 | 0 | 0 | 0 | For |
| American Century | 543,216 | 0 | 0 | 0 | For |
| Charles Schwab | 522,918 | 0 | 0 | 0 | For |
| Northern Trust | 521,422 | 42 | 0 | 0 | For |
| Invesco | 0 | 514,385 | 0 | 0 | Against |
| Holocene Advisors, LP | 492,916 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 463,769 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 418,404 | 0 | 0 | 0 | For |
Institutional-manager reports, all 233 managers: 47,352,297 for, 928,472 against, 52,063 abstained, 765 not voted, 33,655 1 year. Showing the 25 largest; see all in the interactive database.
Combines 6 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: APPROVAL OF A NON-BINDING ADVISORY VOTE ON THE FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION PAID TO OUR NAMED EXECUTIVE OFFICERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Lord Abbett | 0 | 0 | 0 | 0 | -- |
| Delaware/Macquarie | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| WILLIAM BLAIR FUNDS | 0 | 0 | 0 | 0 | -- |
| Principal | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Hartford | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
| Manager Directed Portfolios | 0 | 0 | 0 | 0 | -- |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 0 | -- |
| Brown Advisory Funds | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Brighthouse | 0 | 0 | 17,858 | 0 | Abstain |
| FINANCIAL INVESTORS TRUST | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 97 managers: 3,907 for, 17,858 abstained, 34,072,011 1 year, 47,772 3 year. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Wellington | 0 | 0 | 0 | 0 | -- |
| Man Group plc | 0 | 0 | 0 | 0 | -- |
| Rock Springs Capital Management LP | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| New York Life | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| PICTET ASSET MANAGEMENT SA | 0 | 0 | 0 | 0 | -- |
| LORD, ABBETT & CO. LLC | 0 | 0 | 0 | 0 | -- |
| MACQUARIE INVESTMENT MANAGEMENT BUSINESS TRUST | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| Woodline Partners LP | 0 | 0 | 0 | 0 | -- |
| Polar Capital Holdings Plc | 0 | 0 | 0 | 0 | -- |
| BROWN ADVISORY INC | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Holocene Advisors, LP | 0 | 0 | 0 | 0 | -- |
| Ensign Peak Advisors, Inc | 0 | 0 | 0 | 0 | -- |
| Hood River Capital Management LLC | 418,404 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 228 managers: 587,793 for, 765 not voted, 46,177,682 1 year, 597,863 3 year. Showing the 25 largest; see all in the interactive database.
Combines 3 wordings of this item as funds reported it.
99.6% Approved · of votes cast
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2024.
BLUEPRINT MEDICINES CORP.’s own tally for this item (“5. The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting for the fiscal year ending December 31, 2024.”): 60,124,981 for, 198,317 against — passed, per its Form 8-K filed June 14, 2024 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting for the fiscal year ending December 31, 2024.”
Support: 99.6% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 100 asset managers below reported 34,394,142 for, 349 against, 17,858 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 8,825,344 | 0 | 0 | 0 | For |
| Fidelity | 6,004,519 | 0 | 0 | 0 | For |
| T. Rowe Price | 5,448,322 | 0 | 0 | 0 | For |
| BlackRock | 3,279,222 | 0 | 0 | 0 | For |
| Lord Abbett | 1,145,420 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 945,166 | 0 | 0 | 0 | For |
| State Street | 821,787 | 136 | 0 | 0 | For |
| JPMorgan | 724,726 | 0 | 0 | 0 | For |
| American Century | 519,467 | 0 | 0 | 0 | For |
| Charles Schwab | 502,210 | 0 | 0 | 0 | For |
| Invesco | 430,463 | 0 | 0 | 0 | For |
| AllianceBernstein | 428,993 | 0 | 0 | 0 | For |
| WILLIAM BLAIR FUNDS | 350,924 | 0 | 0 | 0 | For |
| Principal | 276,724 | 0 | 0 | 0 | For |
| Equitable | 261,823 | 0 | 0 | 0 | For |
| TIAA | 261,525 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 231,685 | 0 | 0 | 0 | For |
| Hartford | 222,884 | 0 | 0 | 0 | For |
| Jackson National | 221,771 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 212,314 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 202,784 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 201,802 | 0 | 0 | 0 | For |
| John Hancock | 194,000 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,055 | 0 | 0 | 0 | For |
| Brighthouse | 158,646 | 0 | 17,858 | 0 | Mixed |
Showing the 25 largest of 100 asset managers. See all 100 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 62,616,902 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 14.09% |
| 2 | Fidelity | 9.59% |
| 3 | T. Rowe Price | 8.70% |
| 4 | BlackRock | 5.24% |
| 5 | Lord Abbett | 1.83% |
| 6 | Delaware/Macquarie | 1.51% |
| 7 | State Street | 1.31% |
| 8 | JPMorgan | 1.16% |
| 9 | American Century | 0.83% |
| 10 | Charles Schwab | 0.80% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 11.19% |
| 2 | Fidelity | 8.19% |
| 3 | Wellington | 6.17% |
| 4 | Man Group plc | 4.79% |
| 5 | Rock Springs Capital Management LP | 3.99% |
| 6 | BlackRock | 3.38% |
| 7 | New York Life | 3.19% |
| 8 | State Street | 3.17% |
| 9 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 2.35% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.16% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| T. Rowe Price | 9.98% | 13F |
| The Vanguard Group | 9.77% | 13G |
| Wellington Management | 6.67% | 13F |
| State Street | 3.50% | 13F |
| Geode Capital | 2.19% | 13F |
| Invesco | 1.29% | 13F |
| Norges Bank | 0.90% | 13F |
| Northern Trust | 0.89% | 13F |
| Charles Schwab | 0.80% | 13F |
| D.E. Shaw | 0.61% | 13F |
Percentages above are of 62,616,902 shares outstanding, as reported by BLUEPRINT MEDICINES CORP. on its Form 10-Q dated April 30, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BLUEPRINT MEDICINES CORP.’s 10-Q dated April 30, 2024. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At BLUEPRINT MEDICINES CORP.'s shareholder meeting held June 12, 2024, in the 2023-2024 proxy season, 309 asset managers reported how they voted in their SEC Form N-PX filings, covering 3,449 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL OF A NON-BINDING ADVISORY VOTE ON THE COMPENSATION PAID TO OUR NAMED EXECUTIVE… — BLUEPRINT MEDICINES CORP.'s filing reports the proposal as approved, with 98% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: BLUEPRINT MEDICINES CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 14, 2024.
BLUEPRINT MEDICINES CORP. proxy season coverage: 2023-2024 (this page) · 2024-2025.
Download data (CSV): ballot items · votes by manager · column guide.